Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience
Crossref DOI link: https://doi.org/10.1007/s12032-016-0753-9
Published Online: 2016-03-19
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bupathi, M.
Ahn, D. H.
Wu, C.
Ciombor, K. K.
Stephens, J. A.
Reardon, J.
Goldstein, D. A.
Bekaii-Saab, T.
Text and Data Mining valid from 2016-03-19